Key Financial Data Of Group

OncoTherapy Science, Inc. - Filing #7711247

Concept As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-2,168,507,000 JPY
-2,959,032,000 JPY
-2,683,874,000 JPY
-2,977,177,000 JPY
-2,997,616,000 JPY
-3,008,665,000 JPY
-2,899,152,000 JPY
-2,963,026,000 JPY
-2,122,115,000 JPY
-1,939,855,000 JPY
Profit (loss) attributable to owners of parent
-2,934,960,000 JPY
-2,851,092,000 JPY
-3,002,063,000 JPY
-2,788,819,000 JPY
-1,334,890,000 JPY
Comprehensive income
-3,192,620,000 JPY
-2,927,183,000 JPY
-3,001,558,000 JPY
-2,787,834,000 JPY
-1,321,290,000 JPY
Net assets
4,870,306,000 JPY
4,177,619,000 JPY
7,094,476,000 JPY
7,579,839,000 JPY
10,104,297,000 JPY
9,776,959,000 JPY
12,781,353,000 JPY
13,114,619,000 JPY
15,720,845,000 JPY
16,063,589,000 JPY
Total assets
5,367,176,000 JPY
4,634,717,000 JPY
7,494,683,000 JPY
8,021,524,000 JPY
10,592,771,000 JPY
10,261,458,000 JPY
13,326,748,000 JPY
13,663,124,000 JPY
16,243,242,000 JPY
16,608,437,000 JPY
Net assets per share
30.32
25.75
45.89
47.44
65.97
63.74
84.10
86.36
102.89
105.22
Basic earnings (loss) per share
-23.05
-19.90
-17.85
-19.39
-20.37
-20.42
-18.90
-18.97
-12.44
-9.09
Diluted earnings per share
Equity-to-asset ratio
0.856 xbrli:pure
0.842 xbrli:pure
0.900 xbrli:pure
0.870 xbrli:pure
0.916 xbrli:pure
0.913 xbrli:pure
0.928 xbrli:pure
0.929 xbrli:pure
0.931 xbrli:pure
0.931 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-2,373,427,000 JPY
-3,035,947,000 JPY
-2,988,040,000 JPY
-2,898,286,000 JPY
-1,702,607,000 JPY
Net cash provided by (used in) investing activities
-74,207,000 JPY
-446,421,000 JPY
-11,958,000 JPY
10,883,355,000 JPY
1,884,414,000 JPY
Net cash provided by (used in) financing activities
565,971,000 JPY
150,640,000 JPY
2,330,000 JPY
12,445,000 JPY
68,467,000 JPY
Cash and cash equivalents
4,857,670,000 JPY
6,740,238,000 JPY
10,072,962,000 JPY
13,070,294,000 JPY
5,071,807,000 JPY
Number of employees
63 xbrli:pure
xbrli:pure
37 xbrli:pure
37 xbrli:pure
26 xbrli:pure
37 xbrli:pure
40 xbrli:pure
56 xbrli:pure
54 xbrli:pure
54 xbrli:pure
55 xbrli:pure
55 xbrli:pure
53 xbrli:pure
55 xbrli:pure
Average number of temporary employees
10 xbrli:pure
xbrli:pure
8 xbrli:pure
8 xbrli:pure
2 xbrli:pure
8 xbrli:pure
8 xbrli:pure
8 xbrli:pure
9 xbrli:pure
9 xbrli:pure
9 xbrli:pure
9 xbrli:pure
13 xbrli:pure
13 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.